MYLAN recalls all batches of blood pressure drug in USA

admin December 5, 2018No Comments

Mylan recalls blood pressure drugs over cancer concern

Pharmaceutical firm Mylan is dramatically expanding a nationwide recall of some blood pressure medications after detecting trace amounts of a chemical linked to cancer. The recalled products all contain Valsartan, which is used to treat high blood pressure and heart failure.

Mylan said in an announcement posted on the the U.S. Food and Drug Administration’s website that the drugs — which were sold in the U.S. between March 2017 and November 2018 — show trace amounts of the chemical N-nitrosodiethylamine (NDEA). The International Agency for Research on Cancer classifies NDEA as a probable human carcinogen. Research shows the chemical is found in certain pesticides and in tobacco smoke, as well as in water used in industrial processes.

People who take the recalled drugs — which all have Valsartan in their name — should contact their pharmacist or physician about alternative treatments, but continue taking them in the meantime due to to he risks of abruptly stopping, Mylan said.

Mylan on Nov. 20 said it was recalling a total of 15 lots of tablets containing Valsartan. The expanded recall adds another 104 lots, including Amlodipine and Valsartan Tablets, Valsartan Tablets and Valsartan and Hydrochlorothiazide Tablets, with varying strengths. All have expiration dates in 2019 and 2020 (see full list here or check images below.)

Mylan did not immediately respond to requests for information on how many bottles might be on consumers’ shelves.

Continue at: https://www.cbsnews.com/news/mylan-recalls-blood-pressure-drugs-valsartan-cancer/

The text above is owned by the site above referred.

Here is only a small part of the article, for more please follow the link

Also see:

www.manostaxx.com